BiotechTube

cTIV

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Seasonal Influenza Vaccine

Conditions

Seasonal Influenza Vaccine

Trial Timeline

Jul 1, 2007 โ†’ Aug 1, 2007

NCT ID
NCT00511914

About cTIV

cTIV is a phase 3 stage product being developed by Novartis for Seasonal Influenza Vaccine. The current trial status is completed. This product is registered under clinical trial identifier NCT00511914. Target conditions include Seasonal Influenza Vaccine.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00511914Phase 3Completed

Competing Products

20 competing products in Seasonal Influenza Vaccine

See all competitors
ProductCompanyStageHype Score
Bilastine + Desloratadine + PlaceboYuhanPhase 3
77
ASP4070 + PlaceboAstellas PharmaPhase 2
52
S-555739 Dose 1 + S-555739 Dose 2 + Cetirizine HCl Dose 1 + S-555739 placebo + Cetirizine HCl placeboShionogiPhase 2
52
Cetirizine + High dose ONO-4053 + Low dose ONO-4053 + PlaceboOno PharmaceuticalPhase 2
52
Ciclesonide nasal aerosol 37 mcg + ciclesonide nasal aerosol 74 mcg + PlaceboSumitomo PharmaPhase 3
77
80 mcg Ciclesonide + 160 mcg Ciclesonide + PlaceboSumitomo PharmaPhase 3
77
Ciclesonide HFA 160 ฮผg + Ciclesonide HFA 80 ฮผg + PlaceboSumitomo PharmaPhase 3
77
GSP 301-1 NS (QD) + GSP 301-2 NS (BID) + GSP 301 Placebo NS + Olopatadine HCl-1 NS (QD) + Olopatadine HCl-2 NS (BID) + Mometasone Furoate-1 NS (QD) + Mometasone Furoate-2 NS (BID)Glenmark PharmaceuticalsPhase 2
52
Molo 1 (also referred as GSP 301-2 NS) + Molo 2 (also referred as GSP 301-1 NS) + Placebo nasal spray + DYMISTA nasal spray + PATANASE nasal sprayGlenmark PharmaceuticalsPhase 2
52
JNJ38224342 + JNJ38224342/placebo + JNJ38224342/placebo + JNJ38224342/placeboJohnson & JohnsonPhase 1
33
Ciclesonide + PlaceboAstraZenecaPhase 3
77
Ciclesonide + PlaceboAstraZenecaPhase 3
77
Ciclesonide HFA + Ciclesonide HFA + Ciclesonide HFA + PlaceboAstraZenecaPhase 2
52
budesonide + PlaceboAstraZenecaPhase 2
52
Ciclesonide + PlaceboAstraZenecaPhase 3
77
Ciclesonide Nasal SprayAstraZenecaPhase 3
77
Budesonide + Fluticasone propionate + PlaceboAstraZenecaPhase 3
77
Ciclesonide + Ciclesonide PlaceboAstraZenecaPhase 3
77
loratadineMerckPre-clinical
23
MK0524MerckPhase 2
52

Other Products from Novartis

LCZ696Approved
85
zoledronic acidApproved
85
NateglinideApproved
85
TenofovirApproved
85
FTY720Approved
85